Aquestive Therapeutics Overview
Aquestive Therapeutics Discounted Cash Flow
DCF Analysis for AQST.
Get informed when a big investor buys or sells
+ FollowFair Value
$-1.87
Current Fair Value
$-1.87
↓ 139.7% Downside
Overvalued by 139.7% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison